Magnetic Bead Aggregation Assay for Point-of-Care STI Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current bio-separation techniques, such as liquid chromatography and electrophoresis, are slow and difficult to implement, especially for point-of-care testing for sexually transmitted infections (STIs), as they require pre-treatment and have limited dynamic range and multiplexing capabilities, failing to provide quantitative measurements of specific particles.

Innovation Solution

A magnetic bead aggregation assay system that aggregates magnetic beads in the presence of a magnetic field, allowing for the formation of aggregates with detectable physical properties, enabling characterization and detection of target analytes using a detector to measure these properties on an aggregate-by-aggregate basis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If liquid chromatography or electrophoresis is used for bio-separation, then high resolution separation is achieved, but analysis time is excessive and implementation is difficult

Engineering Contradiction:
Improveseparation resolutionVSAvoidanalysis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces complex mechanical separation systems (liquid chromatography, electrophoresis) with a magnetic field-based aggregation system. Magnetic beads functionalized with capture probes aggregate target analytes through magnetic forces, eliminating the need for complex mechanical separation apparatus while achieving rapid separation and detection within minutes

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the detection parameter from measuring continuous separation processes to measuring discrete magnetic bead aggregate properties (such as aggregate size, magnetic moment, or optical properties). This parameter change enables rapid quantification of analytes based on aggregate characteristics rather than requiring time-consuming separation processes

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If conventional point of care testing is used, then portability is improved, but sensitivity is insufficient for detecting low antigen levels

Engineering Contradiction:
ImproveportabilityVSAvoiddetection sensitivity
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent introduces magnetic beads functionalized with capture probes as intermediaries between the sample and detection system. These beads concentrate target analytes through specific binding, amplifying the signal for low-abundance targets while maintaining assay simplicity suitable for point-of-care settings

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent performs preliminary enrichment and concentration of target analytes on magnetic bead surfaces before detection. This preliminary action on the beads allows the system to detect low antigen levels that would be below the detection threshold of conventional point-of-care tests

Inventive Principle:
Principle #10Preliminary action

3Difficulty of detecting and measuring

If light scattering or fluorescence assays are used, then detection capability is provided, but quantitative measurement of individual particles is not possible

Engineering Contradiction:
Improvedetection capabilityVSAvoidquantitative measurement capability
Core Design Contradiction:
Difficulty of detecting and measuringVSMeasurement precision

Solution Approach 1:

The patent segments the detection approach by functionalizing individual magnetic beads with capture probes, allowing each bead to independently bind and report on target analyte presence. This segmentation enables counting and quantification of individual particle events rather than measuring bulk optical properties

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent utilizes changes in optical properties (such as light scattering intensity or fluorescence) of magnetic bead aggregates as they form and grow. These optical changes provide quantitative information about aggregate size and composition, enabling precise measurement of individual particle events

Inventive Principle:
Principle #32Color changes

4Difficulty of detecting and measuring

If traditional aggregation assays monitoring turbidity or chain length are used, then aggregation detection is achieved, but dynamic range is limited and multiplexing is difficult

Engineering Contradiction:
Improveaggregation detectionVSAvoiddynamic range and multiplexing capability
Core Design Contradiction:
Difficulty of detecting and measuringVSAdaptability or versatility

Solution Approach 1:

The patent creates a universal magnetic bead aggregation platform that can detect various analytes by changing only the capture probe on the beads. The same magnetic detection methodology applies across different analyte types, enabling multiplexing and broad adaptability while maintaining simple aggregation detection

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent measures multiple parameters of magnetic bead aggregates (such as aggregate size distribution, magnetic moment, or optical properties) to extend the dynamic range of detection. By monitoring changes in these parameters as aggregation progresses, the system can quantify analytes across a broader concentration range and differentiate between multiple targets

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides a rapid, accurate, and sensitive assay for detecting analytes, improving point-of-care testing by enabling efficient aggregation and characterization of magnetic bead aggregates, enhancing sensitivity and multiplexing capabilities while reducing analysis time.

Implementation Method 1

providing a container with a sample solution with beads in the presence of a magnetic field of a first orientation

Methodology Applied
Scientific EffectMagnetic field: Magnetic Field

Implementation Method 2

Allowing the beads to migrate to and collect on a side surface of the container

Methodology Applied
Scientific EffectMagnetic migration: Magnetism

Implementation Method 3

Exposing the beads to a magnetic field of a second orientation to allow formation of aggregates of the beads

Methodology Applied
Scientific EffectMagnetic aggregation: Magnetism

Data Source

PatentUS10386364B2Magnetic bead aggregation assay system
Publication Date: 2019.08.20 UNIV COLLEGE DUBLIN NAT UNIV OF IRELAND DUBLIN
  • US10386364B2 patent drawing
  • US10386364B2 patent drawing
  • US10386364B2 patent drawing

AI summary

There is provided a method of aggregating a plurality of beads in a magnetic bead aggregation assay for subsequent analysis comprising: —providing magnetic beads comprising a capture probe for binding with said target analyte; —reacting the magnetic beads with the sample including a target analyte in a reaction chamber aggregating the magnetic beads in the presence of a magnetic field with the target analyte to allow formation of magnetic bead aggregates having physical properties detectable to enable characterization of the aggregates on an aggregate by aggregate basis using a detector to measure the physical properties of the aggregates. Further provided are a method and system for detecting analytes in a sample by characterizing the magnetic bead aggregates on an aggregate by aggregate basis by measuring physical properties of the aggregates.